An insight into Science Creates
Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities.
Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.





Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is set to open in March 2026 in Bristol’s city centre.
We currently welcome applications from service providers working in legal, IT, grants, cloud, bespoke software and marketing.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.
.webp)


Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, synthetic biology and advanced materials.
Deep Tech has the power to revolutionise industries, create new markets, and improve lives. From AI-driven healthcare to sustainable energy and quantum technologies, it tackles critical global issues.
We specialise in Deep Tech for its potential to drive systemic change and create significant impact, providing patient capital and strategic support to turn groundbreaking ideas into scalable businesses.

Biofuel Evolution is driving the process industries’ transition towards net-zero to fuel a circular bio-economy. Its flagship product BEBlock harnesses the power of data analytics, microbial consortia and bio-electrochemical systems to transform food and organic waste into sustainable bio-based products. By developing a decentralised or localised system, its unique solution addresses critical environmental challenges by eliminating the need for energy-intensive biomass and carbon-intensive feedstock logistics.

VyperCore is accelerating and protecting compute-intensive applications from med tech to cybersecurity. Its novel processor technology changes the performance and security paradigms for existing general-purpose computing workloads. This enhances data processing and scaling capabilities for its customers, tailoring to their specific compute systems and requirements while also improving energy efficiency.

Scarlet Therapeutics is developing a proprietary platform that generates novel red blood cell-based therapeutics (tRBCs) to treat a wide range of diseases. Its technologies are underpinned by learnings from decades of research including the groundbreaking RESTORE clinical study run by NHS Blood and Transplant and the University of Bristol, investigating transfusion of lab-grown blood into patients. By generating tRBCs with high levels of therapeutic proteins from cell lines rather than from donated stem cells, Scarlet Therapeutics aims to address significant efficacy and manufacturing issues faced in the field.



Available for hire for those working in the innovation sector, our versatile spaces can welcome a variety of events.
